Search

everythinglearnresearchcommunity

for

Search:↓

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Metal binding to sodium valproate may be linked to hair loss in epilepsy patients.

PTHrP is important for bone formation and may be targeted for osteoporosis treatment and longevity therapies.

A new accurate and reliable method was developed to measure Spironolactone and Hydrochlorothiazide together in medicines.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Including androgens in hormone therapy may lower breast cancer risk.

A new compound was made that might help treat diseases related to male hormones.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

LGR6+ stem cells may improve bone healing.

High-dose iron therapy improves anemia without affecting IBD treatment.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

Sodium valproate reduced seizures in many patients with resistant epilepsy.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Patient care should come before profit in medicine.

LGD1069 effectively prevents breast tumors in mice without toxicity.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Low-dose oral minoxidil is an effective and safe treatment for hair loss.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Early detection of specific VDR mutations is crucial for effective treatment and better dental outcomes in children with hereditary vitamin D–resistant rickets.